Generic Drug User Fee Amendments

The Generic Drug User Fee Amendments are regulations that require generic drug manufacturers to pay fees to the FDA. These funds support the agency’s efforts to review and approve generic medicines more efficiently, ensuring they meet safety and quality standards. The goal is to help bring affordable generic drugs to market faster while maintaining high safety standards, ultimately benefiting consumers by increasing access to lower-cost medications.